ArticlePreventive medicine reports2019
Differences in human papillomavirus (HPV) vaccine uptake by nativity status among men aged 18-34 years.
Article in Preventive medicine reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Drivers of human papillomavirus vaccine uptake in migrant populations and interventions to improve coverage: a systematic review and meta-analysis.The Lancet. Public health · 2025Pooled it
- Factors Affecting Human Papillomavirus Vaccination in Men: Systematic Review.JMIR public health and surveillance · 2022Pooled it
- Electronic Health Record Alerts for Early Human Papillomavirus Vaccination.JAMA network open · 2026Article
- Exploring College Men's Human Papillomavirus (HPV) Vaccine Behavior and Intention in the United States.Journal of community health · 2025Article
- Associations between english proficiency and HPV vaccine uptake among foreign-born men and women in the United States: a cross-sectional study using data from the National Health Interview Survey.BMC public health · 2025Article
- Nativity and racial/ethnic differences in HPV infection among U.S. adults, NHANES 2007-2016.Frontiers in public health · 2025Article
- Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years.Human vaccines & immunotherapeutics · 2024Article
- Article
- HPV vaccination initiation among white, black and Middle East North African (MENA) males.Preventive medicine reports · 2022Article
- Medical students' knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer.Human vaccines & immunotherapeutics · 2022Article
- Black Nativity and Health Disparities: A Research Paradigm for Understanding the Social Determinants of Health.International journal of environmental research and public health · 2022Review
- Article
- HPV vaccination uptake among foreign-born Blacks in the US: insights from the National Health Interview Survey 2013-2017.Cancer causes & control : CCC · 2022Article
- Geographic Variation in Human Papillomavirus Vaccination Initiation and Completion Among Young Adults in the U.S.American journal of preventive medicine · 2021Article
- Missed Opportunities for Human Papillomavirus Vaccination by Parental Nativity, Minnesota, 2015-2018.Public health reports (Washington, D.C. : 1974)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Annually, about 16,500 HPV-associated cancers occur in the US among men. Data regarding HPV vaccine uptake among men based on nativity status (i.e., US-versus foreign-born) is limited, yet potentially important for informing interventions. We assessed differences in HPV vaccine uptake by nativity status among men aged 18-34 years in the US. The 2014-2017 National Health Interview Survey was examined for men, aged 18-34 years (n = 14,056). HPV vaccine initiation was defined as receipt of at least one dose of the vaccine and completion as receipt of three doses. Weighted, multivariable binary logistic regression models were used to assess the association between nativity status and HPV vaccine uptake, adjusting for demographic, socioeconomic, and healthcare factors. Analyses were performed in July 2018. Overall, 17% of men self-identified as foreign-born, 9.9% of men had initiated the HPV vaccine, and 3.3% had completed the HPV vaccine. Among foreign-born men, Asians had the highest HPV vaccination rates whereas those from Indian subcontinental region had the lowest rates. After accounting for demographic, socioeconomic, and healthcare factors, compared to US-born men, foreign-born men were 46% (adjusted odds ratio = 0.54; 95% CI = 0.39-0.72) less likely to initiate the HPV vaccine but there was no difference between the two groups in terms of vaccine completion. We found that HPV vaccine uptake among men was very low overall, and foreign-born men had lower initiation compared to US-born men. Public health interventions which improve HPV vaccination need to be developed for all men, irrespective of nativity status.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.